Profile data is unavailable for this security.
About the company
INVO Bioscience, Inc. is a healthcare services fertility company. The Company is focused on expanding the assisted reproductive technology (ART) marketplace by making fertility care accessible and inclusive to people around the world. The Company’s flagship product is INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. Its treatment solution is the intravaginal culture technique for the incubation of oocytes and sperm during fertilization and early embryo development. Its technique, designated as IVC, provides patients a more connected and intimate experience at a more affordable cost in comparison to in vitro fertilization (IVF), the other advanced ART treatment. Its commercialization strategy is focused on the opening of INVO Centers offering the INVOcell and IVC procedure and the acquisition of existing IVF clinics. The Company operates three INVO Centers in North America.
- Revenue in USD (TTM)3.02m
- Net income in USD-8.03m
- Incorporated2005
- Employees25.00
- LocationINVO Bioscience Inc5582 Broadcast CtLAKEWOOD RANCH 34240-8471United StatesUSA
- Phone+1 (978) 878-9505
- Websitehttps://invobioscience.com/
More ▼
Mergers & acquisitions
| Acquired company | INVO:NAQ since announced | Transaction value |
|---|---|---|
| NAYA Biosciences Inc | 86.80% | 71.87m |
Data delayed at least 15 minutes, as of May 10 2024 20:47 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grapefruit USA Inc | 34.85k | -4.37m | 1.38m | 9.00 | -- | -- | -- | 39.70 | -0.008 | -0.008 | 0.00006 | -0.0101 | 0.0121 | 1.31 | 0.2259 | 3,872.22 | -151.85 | -268.93 | -- | -- | -1,304.65 | -10.09 | -12,531.68 | -408.87 | 0.0388 | -1.50 | -- | -- | -83.96 | 77.87 | -35.68 | -- | -- | -- |
| Kelyniam Global Inc | 517.70k | -420.28k | 1.42m | 0.00 | -- | 2.66 | -- | 2.75 | -0.0253 | -0.0253 | 0.0312 | 0.0179 | 0.4135 | 7.04 | 4.38 | -- | -33.57 | -- | -41.79 | -- | 18.86 | -- | -81.18 | -- | 1.26 | -- | 0.6232 | -- | -26.47 | -- | -19.10 | -- | -- | -- |
| Escalon Medical Corp | 12.38m | 450.50k | 1.48m | 38.00 | 7.72 | 1.58 | 2.99 | 0.1198 | 0.0259 | 0.0259 | 1.18 | 0.1951 | 2.65 | 4.04 | 8.01 | 325,898.70 | 14.68 | -1.76 | 35.71 | -3.67 | 46.26 | 44.57 | 5.54 | -0.9114 | 1.09 | 31.90 | 0.1504 | -- | 13.80 | 1.33 | 760.89 | -17.06 | -19.85 | -- |
| Bone Biologics Corp | 0.00 | -8.95m | 1.58m | 2.00 | -- | 0.3309 | -- | -- | -77.05 | -77.05 | 0.00 | 5.44 | 0.00 | -- | -- | 0.00 | -146.30 | -98.31 | -202.15 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -502.76 | -- | -- | -- |
| Acutus Medical Inc | 7.16m | -11.92m | 1.77m | 233.00 | -- | -- | -- | 0.2469 | -0.4097 | -0.417 | 0.2467 | -0.0308 | 0.0765 | 1.17 | 0.4417 | 30,746.78 | -12.72 | -46.76 | -16.05 | -56.88 | -43.79 | -89.12 | -166.40 | -773.49 | 2.22 | -6.78 | 1.03 | -- | 136.36 | 27.03 | -141.35 | -- | -35.99 | -- |
| NanoVibronix Inc | 2.28m | -3.71m | 2.12m | 10.00 | -- | 0.3908 | -- | 0.929 | -2.15 | -2.15 | 1.30 | 1.95 | 0.3637 | 0.3041 | 13.96 | 228,300.00 | -59.13 | -116.16 | -95.36 | -169.36 | 67.32 | 50.47 | -162.55 | -570.47 | 1.53 | -13.97 | 0.00 | -- | 203.59 | 48.33 | 31.88 | -- | -34.02 | -- |
| InnerScope Hearing Technologies, Inc. | 334.45k | -7.15m | 2.14m | 24.00 | -- | -- | -- | 6.40 | -0.0153 | -0.0153 | 0.0002 | -0.0028 | 0.0955 | 3.93 | 1.71 | -- | -204.11 | -27.82 | -- | -94.53 | 17.79 | 58.17 | -2,138.50 | -42.13 | 0.0022 | -0.4232 | -- | -- | -- | 100.59 | -- | -- | 233.50 | -- |
| SINTX Technologies Inc | 2.63m | -8.29m | 2.23m | 43.00 | -- | 0.0265 | -- | 0.8497 | -2.03 | -2.03 | 0.7041 | 1.65 | 0.1687 | 1.34 | 5.19 | 61,093.02 | -53.05 | -45.71 | -81.96 | -57.36 | 70.16 | 58.47 | -314.39 | -681.80 | 1.60 | -- | 0.0052 | -- | 68.29 | 94.24 | 49.75 | -- | 54.10 | -- |
| Therapeutic Solutions International Inc | 98.99k | -2.17m | 2.33m | 3.00 | -- | 1.86 | -- | 23.50 | -0.0007 | -0.0007 | 0.00003 | 0.0003 | 0.0287 | 1.13 | 4.44 | 32,996.67 | -64.51 | -162.32 | -169.11 | -- | 62.85 | 67.79 | -2,247.41 | -2,391.85 | 0.0333 | -4.92 | 0.373 | -- | -52.13 | 95.35 | 43.11 | -- | -- | -- |
| Dynatronics Corp | 35.18m | -5.70m | 2.39m | 154.00 | -- | 0.2941 | -- | 0.068 | -1.38 | -1.38 | 8.39 | 3.43 | 1.09 | 3.16 | 7.84 | 228,421.30 | -15.46 | -6.02 | -21.69 | -8.30 | 21.52 | 27.33 | -14.12 | -4.55 | 0.6695 | -19.74 | 0.1955 | -- | -8.41 | -8.81 | -19.84 | -- | -5.11 | -- |
| Invo Bioscience Inc | 3.02m | -8.03m | 2.50m | 25.00 | -- | -- | -- | 0.8278 | -9.13 | -9.13 | 2.57 | 0.3582 | 0.2417 | 6.73 | 27.75 | 120,822.80 | -64.30 | -94.63 | -120.25 | -151.45 | 41.20 | 74.91 | -266.00 | -343.11 | 0.1211 | -6.86 | 0.7558 | -- | 267.38 | 43.62 | 26.24 | -- | 87.09 | -- |
| VirExit Technologies Inc | 0.00 | -1.80m | 2.56m | -- | -- | -- | -- | -- | -0.0932 | -0.113 | 0.00 | -0.0367 | 0.00 | -- | -- | -- | -6,103.43 | -- | -- | -- | -- | -- | -- | -- | -- | -3.66 | -- | -- | -100.00 | -- | 19.08 | -- | -- | -- |
| Vycor Medical Inc | 1.46m | -387.45k | 2.74m | 8.00 | -- | -- | -- | 1.88 | -0.0122 | -0.0124 | 0.0432 | -0.1019 | 1.58 | 0.6002 | 7.86 | 182,575.00 | -6.81 | -47.86 | -- | -- | 90.08 | 89.60 | -4.32 | -35.42 | 0.0859 | 0.389 | -- | -- | 19.43 | -0.6542 | 46.49 | -- | -31.77 | -- |
| Aethlon Medical, Inc. | 574.25k | -12.26m | 3.09m | 15.00 | -- | 0.4022 | -- | 5.38 | -5.03 | -5.03 | 0.2362 | 2.93 | 0.0369 | -- | -- | 38,283.33 | -78.62 | -75.30 | -92.02 | -84.98 | -- | -- | -2,133.17 | -1,783.78 | -- | -- | 0.00 | -- | 95.21 | 30.86 | -15.55 | -- | 106.99 | -- |
| Tenon Medical Inc | 2.93m | -15.58m | 3.13m | 21.00 | -- | 2.81 | -- | 1.07 | -10.28 | -10.28 | 1.62 | 0.2992 | 0.3359 | 3.48 | 7.85 | 139,428.60 | -178.74 | -- | -264.89 | -- | 42.38 | -- | -532.14 | -- | 1.06 | -- | 0.6012 | -- | 323.73 | -- | 17.63 | -- | -- | -- |
Data as of May 10 2024. Currency figures normalised to INVO Bioscience Inc's reporting currency: US Dollar USD
4.56%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 54.06k | 2.18% |
| Geode Capital Management LLCas of 31 Dec 2023 | 26.83k | 1.08% |
| Sabby Management LLCas of 31 Dec 2023 | 18.62k | 0.75% |
| UBS Securities LLCas of 31 Dec 2023 | 7.16k | 0.29% |
| Tower Research Capital LLCas of 31 Dec 2023 | 4.95k | 0.20% |
| Securities America Advisors, Inc.as of 31 Dec 2023 | 559.00 | 0.02% |
| City National Rochdale LLCas of 31 Dec 2023 | 538.00 | 0.02% |
| Aspire Private Capital LLCas of 31 Mar 2024 | 115.00 | 0.01% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2023 | 37.00 | 0.00% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 24.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
